Pazopanib in Patients with Osteosarcoma Metastatic to the Lung: Phase 2 Study Results and the Lessons for Tumor Measurement

Figure 2

Growth rates in patients with clinical benefit with pazopanib.

(a)

(b)

(c)

(d)

(e)

(f)